A Canterbury woman dismissed postmenopausal bleeding as a menopause symptom—only to be diagnosed with womb cancer. Now cancer ...

Osteoporosis, often called a silent disease, weakens bones and increases the risk of fractures, making it a leading cause of ...

The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.

Osteoporosis, often called a silent disease, weakens bones and increases the risk of fractures, making it a leading cause of ...

Recently postmenopausal women with elevated blood pressure but no other CVD risk factors were more likely to develop white matter lesions 14 years later, regardless of short-term hormone therapy use, ...

Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis.

Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis, according to a study published online Jan. 18 in Scientific Reports.

Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with vulvovaginal atrophy treated with prasterone had lower UTI prevalence. Women who ...

Mikayla Spangler, Pharm.D., BCPS; Beth Bryles Phillips, Pharm.D., FCCP, BCPS; Mary B. Ross, M.B.A.; Kevin G. Moores, Pharm.D.

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.